SA
HLLGY logo
HELLA GmbH & Co. KGaA(HLLGY)
Closing price · checked 10:37 PM ETAbout this dataData status
$40.21▲0.00 (0.00%)
Extended:$40.21+0.00 (+0.00%)· 10:37 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

HELLA GmbH & Co. KGaA (HLLGY)

R&D to Revenue

9.79%

Fiscal year · Period ending:

HLLGY logo

HLLGY R&D to Revenue

Latest reported9.79%
HLLGY FY R&D/Revenue (8.33% → 9.79%)
Powered by
High-resolution chart · PNG

What is r&d to revenue?

R&D spending as percentage of revenue.

HLLGY r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it, in percentage points.

HELLA GmbH & Co. KGaA R&D to Revenue — Annual fiscal periods
Period endingR&D to RevenueChange
9.7942%−0.31 pts
10.1027%−0.93 pts
11.0346%+0.66 pts
10.3786%−0.52 pts
10.8975%+0.39 pts
10.5078%−0.17 pts
10.682%+8.90 pts
1.7855%−8.02 pts
9.8017%+0.14 pts
9.6624%−0.15 pts
9.8153%+0.49 pts
9.3224%−0.29 pts
9.611%+0.25 pts
9.3653%+1.29 pts
8.0718%+0.16 pts
7.9072%−0.42 pts
8.3316%—

Frequently asked questions: HLLGY r&d to revenue

What is HELLA GmbH & Co. KGaA (HLLGY)'s current r&d to revenue?

HELLA GmbH & Co. KGaA (HLLGY)'s latest reported r&d to revenue (Fiscal year) is 9.79% as of Dec 31, 2025. R&D spending as percentage of revenue.

How much historical r&d to revenue data is available for HLLGY?

Stock Alarm Pro provides 17 dated annual fiscal periods observations for HELLA GmbH & Co. KGaA (HLLGY)'s r&d to revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare HLLGY's r&d to revenue to peers or set an alert?

You can open HLLGY's r&d to revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on HLLGY delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.